Targeting Regulatory T Cells for Anticancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|11|6|480-485

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.6, 2011-06, pp. : 480-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Phosphatidylserine in Anti-Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 15, Iss. 23, 2009-08 ,pp. : 2719-2723

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory T Cell Therapy for Type I Diabetes Targeting on bgr; Cell Associated Autoantigens

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 3, Iss. 1, 2016-06 ,pp. : 47-53

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581

By Banham Alison H   Pulford Karen  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 7, 2009-07 ,pp. : 1023-1028

Informa Healthcare

Access to resources Recommend Favorite

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

By  

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Mevalonate Pathway for Improved Anticancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 626-638

Bentham Science Publishers

Access to resources Recommend Favorite